mRNA-3351

N/A

Report date: 2024/06/26 16:28:41

Base Information

Drug NamemRNA-3351
Drug Alias NamemRNA-3351ALXN-1540
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionUDP-glucuronosyltransferase 1-1 gene transference
TargetsUDP-glucuronosyltransferase 1-1
Therapy Area/IndicationsCrigler-Najjar Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesModerna Inc
China Registration ClassN/A

Develop Information

Active CompaniesModerna IncThe Institute for Life Changing Medicines
Inactive CompaniesN/A
Active IndicationsCrigler-Najjar Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A